Cargando…
Dose-Dependent Targeted Suppression of P-glycoprotein Expression and Function in Caco-2 Cells
[Image: see text] The efflux transporter P-glycoprotein (Pgp), encoded by the ABCB1 gene, decreases the bioavailability of a wide range of orally administered drugs. Drug permeability studies using the in vitro Caco-2 cell model commonly rely on small molecule modulators to estimate the contribution...
Autores principales: | Lee, Stephen D., Osei-Twum, Jo-Ann, Wasan, Kishor M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674641/ https://www.ncbi.nlm.nih.gov/pubmed/23611024 http://dx.doi.org/10.1021/mp300668e |
Ejemplares similares
-
The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within Caco-2 cells
por: Sachs-Barrable, Kristina, et al.
Publicado: (2014) -
Effect of dietary fat on hepatic liver X receptor expression in P-glycoprotein deficient mice: implications for cholesterol metabolism
por: Thornton, Sheila J, et al.
Publicado: (2008) -
Differences in Breast Cancer Presentation at Time of Diagnosis for Black and White Women in High Resource Settings
por: Osei-Twum, Jo-Ann, et al.
Publicado: (2021) -
Use of a Caco-2 permeability assay to evaluate the effects of several Kampo medicines on the drug transporter P-glycoprotein
por: Matsumoto, Takashi, et al.
Publicado: (2018) -
An Investigation into the Role of P-Glycoprotein in the Intestinal Absorption of Repaglinide: Assessed by Everted Gut Sac and Caco-2 Cell Line
por: Yaghoobian, Morteza, et al.
Publicado: (2019)